• Key Features & Attributes
  • Ratings & Reviews
  • Know your Supplier
  • Product description from supplier

Letrozole Tablets IP 2.5 mg

Inclusive of all taxes

Letrozole Tablets IP 2.5 mg are meticulously formulated pharmaceutical tablets designed specifically for the management of gynecology conditions. Manufactured under stringent WHO-GMP certified facilities by IndiGlobal Exports, these tablets guarantee precise dosing and consistent therapeutic efficacy for patients requiring hormone-related treatments in gynecological care. Each tablet contains a 2.5 mg dose of letrozole, an active nonsteroidal aromatase inhibitor widely prescribed for hormone-sensitive gynecological disorders. The product is packaged in export-grade blister or strip packs, ensuring protection, stability, and compliance with international pharmaceutical standards. Suitable for hospital pharmacies, retail pharmacies, and bulk institutional supply, these tablets meet IP pharmacopoeial requirements, making them ideal for markets requiring export-quality products compliant with global healthcare regulations.

Key Features

Features Description
Active Ingredient Letrozole 2.5 mg per tablet
Indication Management of gynecology hormone-related conditions
Formulation Type Oral Tablet
Packaging Export-grade blister / strip packs
Manufacturing Compliance WHO-GMP certified facilities
Therapeutic Performance Consistent dosage and reliable efficacy
Market Suitability Suitable for international pharmaceutical markets
Shelf Life As per regulatory standards
Manufacturer IndiGlobal Exports
Attributes Description
Category Gynecology
Dosage Strength 2.5 mg
Pharmacopoeia Standard Indian Pharmacopoeia (IP) / USP compliant
Dosage Form Tablet
Packaging Type Blister or strip pack
Shelf Life Duration As per regulatory guidelines
Therapeutic Class Aromatase inhibitor
Intended Use Clinical treatment of hormone-responsive gynecological disorders
Manufacturing Location WHO-GMP certified facility by IndiGlobal Exports

*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.

Be the first to write a review

Yes, Letrozole Tablets IP 2.5 mg are manufactured under stringent WHO-GMP standards, packaged in export-grade blister or strip packs, making them fully compliant with international pharmaceutical export requirements.

These tablets are produced in WHO-GMP certified facilities following Indian Pharmacopoeia (IP) and USP standards to ensure consistent dosage, potency, and therapeutic efficacy.

The tablets are precisely formulated with 2.5 mg of letrozole, ensuring uniform active pharmaceutical ingredient distribution for reliable hormonal therapy in gynecology conditions.

The tablets are available in export-grade blister packs or strip packs that provide adequate protection from moisture, light, and contamination, ensuring shelf life and product integrity during transit.

Yes, Letrozole Tablets IP 2.5 mg are designed for bulk supply suitable for institutional procurement, hospital pharmacies, and retail pharmacy outlets.

  • Incorporation Type

  • GST

  • GST Registration Date

  • Number of Employees

  • Import Export Code (IEC)

  • Year of Establishment

  • Nature of Business

  • GlobalLinker Member Since

Brand: indiglobal exports

Country Of Origin: India

Letrozole Tablets IP 2.5 mg is a pharmaceutical product indicated for gynecology treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.

Features:
  • Used in the management of gynecology conditions
  • Precise dosage form and active pharmaceutical ingredients
  • Suitable for international pharmaceutical markets
  • Manufactured in GMP-compliant facilities
  • Reliable therapeutic performance
Attributes:
  • Category: Gynecology
  • Formulation: Tablet
  • Packaging: Export-grade blister or strip packs
  • Shelf Life: As per regulatory standards
  • Manufacturer: IndiGlobal Exports
Product Overview

Letrozole Tablets IP 2.5 mg is developed for the effective management of gynecology conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.


Therapeutic Use & Application

This formulation supports the clinical treatment and ongoing care of patients with gynecology indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.


Formulation & Packaging

Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.


Quality & Compliance

The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.



Contraceptive Medications

indiglobal exports

Letrozole Tablets 2.5 Mg

Gynecology Medication

Hormone Therapy Tablets

Aromatic Inhibitor Tablets

Export Quality Letrozole

Gynecology Treatment Drugs

IndiGlobal Exports Medicine

WHO GMP Pharmaceutical

Letrozole IP Tablets

Bulk Gynecology Tablets

Letrozole Tablets IP 2.5 mg

Inclusive of all taxes

You Save: 0

Send Inquiry
indiglobal exports

Panchkula , India

Service Provider , Professional Services, Exporter, Wholesaler

GST- 06eogps3248l1zf

  • Secure
    Transaction

  • Free
    Delivery

  • Day
    Dispatch

Report a problem with this product